The public can still have faith in the efficacy of vaccines despite new research showing they are less effective against the South African variant of the CCP virus, the UK’s vaccine deployment minister Nadhim Zahawi said on Monday. A new study has found that the Oxford/AstraZeneca vaccine provides minimal protection against mild and moderate cases of the South African variant of the CCP (Chinese Communist Party) virus, also known as the novel coronavirus. The jab’s efficacy against severe disease caused by the variant, hospitalisations, and deaths has not yet been determined, according to the study, which was led by South Africa’s University of the Witwatersrand and the University of Oxford. South African Health Minister Zweli Mkhize said on Sunday the rollout of the Oxford vaccine would be put on hold and that the government would await advice from scientists on how best to proceed. Tests previously conducted by Johnson & Johnson …